New depression drug zuranolone one step closer to FDA ruling
The DOI matches its Crossref record.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The analogous compound zuranolone (SAGE-217), also approved by FDA for the same disorder [152], has an increased oral bioavailability and limited side effects [153,154].”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [154]
Citations
Cites
Still being checked.
Cited by
Fibromyalgia pathogenesis explained by a neuroendocrine multistable model
Demori, I., Losacco, S., Giordano, G., Mucci, V., Blanchini, F., & Burlando, B. (2024) · PLOS ONE · doi:10.1371/journal.pone.0303573 · Cited by 14
Metadata
- Authors
- Carvalho, T.
- Corresponding author
- Carvalho, Thiago
- Venue
- Nature Medicine
- Published
- 2023-04-11
- Volume
- 29
- Issue
- 5
- Pages
- 1032-1033
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4364377484
- Cited by
- 6
- References
- 0
- Citations by year
- 2026: 1 · 2024: 4 · 2023: 1
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- zuranolone, depression, GABA agonists, new drug applications, FDA approval, Biogen, drug development
- MeSH terms
- Depression, Humans, Pregnanes, Pregnanolone, Pyrazoles, United States, United States Food and Drug Administration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New depression drug zuranolone one step closer to FDA ruling. https://app.cochat.ai/papers/10.1038/d41591-023-00032-8
- The paper
- Carvalho, T. (2023). New depression drug zuranolone one step closer to FDA ruling. Nature Medicine. https://doi.org/10.1038/d41591-023-00032-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.